pyrrolidine dithiocarbamate has been researched along with berotek in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Advenier, C; Candenas, ML; Emonds-Alt, X; Faisy, C; Martin, JD; Molimard, M; Naline, E; Pinto, FM; Prieto, L; Saulnier, JP | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and berotek
Article | Year |
---|---|
SR 142801, a tachykinin NK(3) receptor antagonist, prevents beta(2)-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea.
Topics: Acetylcholine; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Culture Techniques; Dose-Response Relationship, Drug; Drug Synergism; Fenoterol; Gliotoxin; Guinea Pigs; Kinetics; Muscle Contraction; Neurokinin A; NF-kappa B; Phylogeny; Piperidines; Pyrrolidines; Receptors, Neurokinin-3; Receptors, Tachykinin; RNA, Messenger; Thiocarbamates; Trachea | 2002 |